Cutler Group LP Horizon Therapeutics Public LTD CO Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	SELL	$98.98 - $115.74 $3.65 Million - $4.27 Million	-36,900 Reduced 89.13%	4,500 $1,000
Q2 2023 Jul 18, 2023	BUY	$96.34 - $112.38 $3.74 Million - $4.36 Million	38,800 Added 1492.31%	41,400 $34,000
Q1 2023 May 01, 2023	SELL	$107.32 - $113.5 $2.73 Million - $2.88 Million	-25,400 Reduced 90.71%	2,600 $4,000
Q4 2022 Feb 07, 2023	BUY	$62.39 - $113.8 $1.75 Million - $3.19 Million	28,000 New	28,000 $3,000
Q1 2022 Apr 14, 2022	SELL	$86.42 - $109.81 $207,408 - $263,544	-2,400 Reduced 25.0%	7,200 $16,000

Q4 2021 Jan 18, 2022	BUY	$98.56 - $119.91 $374,528 - $455,658	3,800 Added 65.52%	9,600 $19,000
Q3 2021 Oct 26, 2021	BUY	$91.91 - $110.37 $257,348 - $309,036	2,800 Added 93.33%	5,800 $28,000
Q2 2021 Jul 19, 2021	SELL	$86.24 - $95.92 $1.42 Million - $1.58 Million	-16,500 Reduced 84.62%	3,000 $33,000
Q1 2021 Apr 26, 2021	BUY	$71.83 - $95.48 $222,673 - $295,988	3,100 Added 18.9%	19,500 $66,000
Q4 2020 Jan 21, 2021	SELL	$67.0 - $84.39 $911,200 - $1.15 Million	-13,600 Reduced 45.33%	16,400 $19,000
Q3 2020 Oct 27, 2020	BUY	$55.23 - $79.93 $1.66 Million - $2.4 Million	30,000 New	30,000 $59,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.